Skip to content

    Alzheimer's Disease Health Center

    Font Size
    A
    A
    A

    Advances Made Toward Alzheimer’s Blood Test

    Study Shows Synthetic Molecules May Help Detect Alzheimer’s, MS, and Other Diseases
    By
    WebMD Health News
    Reviewed by Laura J. Martin, MD

    Jan. 6, 2011 -- Molecules developed in the lab to seek out antibodies associated with disease could lead to simple blood tests for Alzheimer’s, multiple sclerosis, and a host of other diseases, researchers say.

    The new experimental technology relies on thousands of synthetic molecules known as peptoids to search for antibodies that occur in response to disease.

    The hope is that the man-made molecules will lead to tests to identify diseases like Alzheimer’s and cancer long before symptoms occur, says Thomas Kodadek, PhD, who is a professor of chemistry and cancer biology at the Scripps Research Institute in Jupiter, Fla.

    A New Way to Search for Disease

    Research to identify biomarkers that can be used to screen for disease has largely focused on proteins that are elevated or not elevated for a particular disease state.

    But Kodadek says this has proven to be very difficult because the proteins are hard to find and not very stable.

    Another approach is to look for the antibodies produced by the immune system in response to harmful molecules, or antigens, linked to disease.

    Most of this research has focused on identifying disease-specific antigens, which has also proven to be a major problem, Kodadek says.

    “We took a different approach,” he tells WebMD. “Our approach eliminates the need to know anything about the disease in order to find candidate biomarkers. That is the big breakthrough here.”

    Using large numbers of peptoids, the researchers conducted random screens of blood taken from animals and humans to search for disease-specific antibodies.

    Early studies involved mice with a condition that resembles multiple sclerosis in humans.

    Using the technique, Kodadek and colleagues were able to identify several disease-specific peptoid-antibody pairs in the blood of the sick mice that were not present in healthy mice.

    In a small, pilot study involving Alzheimer’s patients, the researchers identified three peptoid-antibody pairs in the blood of six patients with the age-related dementia that were not present in the blood samples of healthy people or those with Parkinson’s disease.

    The study appears this week in the journal Cell.

    Today on WebMD

    Remember your finger
    When it’s more than just forgetfulness.
    senior man with serious expression
    Which kinds are treatable?
     
    senior man
    Common symptoms to look for.
    mri scan of human brain
    Can drinking red wine reverse the disease?
     
    Checklist
    ARTICLE
    eating blueberries
    ARTICLE
     
    clock
    Article
    Colored mri of brain
    ARTICLE
     
    Human brain graphic
    ARTICLE
    mature woman
    ARTICLE
     
    Woman comforting ailing mother
    ARTICLE
    Senior woman with serious expression
    ARTICLE